The Krebs von den Lungen-6 (KL-6) protein, as a high-molecular weight mucin glycoprotein, predominantly expressed on the surface of AEC II and bronchial epithelial cells [393], was proposed as a biomarker of both ALI/ARDS and pulmonary fibrosis due to its localization and the damage sustained by AECs in both diseases. This evidence concerns the gene MUC1 and pulmonary fibrosis.